| Business

Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

Daily Photo Galleries

Wednesday, June 4, 2014, 10:51 a.m.

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.




Show commenting policy

Most-Read Business Headlines

  1. Retailer rolls dice on TargetExpress
  2. EPA failing to stop natural gas pipeline leaks, internal watchdog says
  3. Car dealers find silver lining in cloud of vehicle recalls
  4. Economists cite signs of strength
  5. Export-Import Bank in dispute in Congress
  6. Citizens Bank parent says 6-month profit doubles
  7. 2 cars put 50 mpg in rearview
  8. China pork giant WH Group makes 2nd IPO attempt
  9. Plug-in Accord makes gas station visits rare
  10. Gas pipeline issues challenge for producers, users
  11. Engine that quits a mystery
Subscribe today! Click here for our subscription offers.